NeuroOne (NMTC) CFO Volker Christopher Receives Award

What Happened

• Volker Christopher, CFO of NeuroOne Medical Technologies Corp (NMTC), received a grant of 35,000 derivative shares on August 28, 2026. The grant was issued at $0.00 per share (award/derivative), so no cash was paid by the insider at grant.

Key Details

• Transaction date: 2026-08-28; transaction type: Grant/Award (derivative).
• Amount: 35,000 shares granted; acquisition price reported as $0.00 (no cash outlay).
• Shares owned after transaction: Not specified in the filing.
• Vesting: Per footnote — 25% vests on August 28, 2027; remaining 75% vests in 12 equal quarterly installments thereafter.
• No 10b5-1 plan, tax withholding, or late filing was indicated in the Form 4.

Context

• This was an equity award (derivative grant), typical for executive compensation; it is not an open-market purchase or sale. Awards reflect compensation and vest over time rather than an immediate cash investment or divestment, so they do not by themselves signal a near-term change in insider sentiment.